SCHEMBL22212600

SCHEMBL22212600

NC(=O)Cn1c2c(c3ccccc31)CCC=C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ GLA P06280 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ PTGDR2 Q9Y5Y4 5/20 0.38
▸ AKR1B10 O60218 2/20 0.37
▸ AKR1B1 P15121 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ IDO1 P14902 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ AKR1A1 P14550 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872138 0.86 KDM4E (0.45) KDM4EGLAMEN1CASP1CASP7
SCHEMBL27883062 0.80 KDM4E (0.59) KDM4EGLAMEN1CASP1CASP7
SCHEMBL30223689 0.79 ALDH1A1 (0.39) KDM4EGLAMEN1CASP1CASP7
SCHEMBL13538135 0.79 ALDH1A1 (0.45) KDM4EMEN1CASP1CASP7KMT2A
SCHEMBL17194083 0.79 CYP1A2 (0.53) KDM4EGLAMEN1CASP1CASP7
SCHEMBL13957372 0.77 CA1 (0.41) KDM4EGLAMEN1CASP1CASP7
SCHEMBL25638913 0.76 PDE5A (0.43) KDM4EMEN1CASP1CASP7KMT2A
SCHEMBL3237173 0.75 KDM4E (0.40) KDM4EGLAMEN1CASP1CASP7
SCHEMBL10063550 0.75 MAOA (0.47) HDAC1HDAC6
SCHEMBL3322075 0.74 KDM4E (0.68) KDM4EGLAHPGDHDAC6IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3680233-A1 NOVEL AMIDE COMPOUND, AND Pin1 INHIBITOR, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES AND THERAPEUTIC AGENT FOR CANCER THAT USE THE SAME Hiroshima University (JP) 2020-07-15 — — EP disclosed
Send feedback